- Semaglutide: an effective antidiabetic agent with proven cardiovascular benefit in clinical practice2020 | First Faculty of Medicine
- Comparison of Polyphenol-Enriched Tomato Juice and Standard Tomato Juice for Cardiovascular Benefits in Subjects with Stage 1 Hypertension: a Randomized Controlled Study2019 | First Faculty of Medicine
- Gliflozins: already checked choice for type 2 diabetics2018 | First Faculty of Medicine
- Modern pharmacologic treatment of type 2 diabetes mellitus2017 | First Faculty of Medicine
- SGLT2 inhibitors and atherosclerosis in a background of effect of gliflozins and heart failure2021 | First Faculty of Medicine
- Diabetes, Lipids, and CV Risk2021 | First Faculty of Medicine
- Cardioascular effect of incretin-based therapies: comparison od DPP-4 inhibitors and GLP-1 agonists2014 | First Faculty of Medicine
- REDUCE-IT study results - new chance for omega-3 fatty acids?2019 | First Faculty of Medicine
- Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril2017 | Faculty of Medicine in Hradec Králové
- Modern antidiabetics in synergy: fixed dose combination empagliflozin/linagliptin2017 | First Faculty of Medicine
- Statin Intolerance: the Clinician's Perspective2015 | First Faculty of Medicine
- Hemodialysis vascular access affects heart function and outcomes: Tips for choosing the right access for the individual patient2021 | First Faculty of Medicine
- Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis2018 | First Faculty of Medicine
- Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease2021 | Third Faculty of Medicine